Worldwide Survey on the Methods, Efficacy, and Safety of Catheter Ablation for Human Atrial Fibrillation

By R. Cappato, H. Calkins, Shih‐Ann Chen, W. Davies, Y. Iesaka, J. Kalman, You-Ho Kim, G. Klein, D. Packer, A. Skanes. Circulation, 2005

1,228 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine

View Paper: https://www.semanticscholar.org/paper/e6e7897f2f306425530b0e0fc976db0b275b5c82

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

Citations in the corpus

Updated Worldwide Survey on the Methods, Efficacy, and Safety of Catheter Ablation for Human Atrial Fibrillation (2005, background): “Discussion There are 8 main observations collected from the present survey: (1) CA is increasingly being offered to patients with AF; (2) it is increasingly being offered to sicker AF patients; (3) 2 mapping/ablation techniques have become established as the most frequently used; (4) PV isolation is”
Catheter Ablation Versus Antiarrhythmic Drugs for Atrial Fibrillation: The A4 Study (2008, neutral): “Structural heart disease, n (%) 10 (19) 14 (24) 24 (26)”
2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design (2012, methodology): “3% incidence of cardiac tamponade, respectively [386, 506].”
Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial. (2005, background): “Structural heart disease and hypertension 8 (25) 10 (28)”
2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation (2017, methodology): “Nonetheless, comparisons of high- and low-volume centers suggest that outcomes are better at centers that have performed more than 100 procedures.(806) Other data report improved outcomes for operators with an annual procedure volume of at least 25 cases and for centers with an annual procedure volu”
Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial. (2010, background): “Major adverse events have been reported in up to 6% of patients undergoing AF ablation, including thromboembolic events, atrialesophageal fistula, cardiac perforation, phrenic nerve paralysis, and death.(12-16,24) None of these more serious complications occurred in our study.”
Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). (2010, background): “Complications Catheter ablation of AF is associated with significant complications (Table 17).(129) –131 Major complications are defined as those that result in permanent injury or death, require intervention for treatment, or prolong or require hospitalization.”